Biota Pharmaceuticals Inc(NASDAQ:BOTA) announced that an interim update has been provided from the U.S. Department of Health and Human Services and the Biomedical Advanced Research and Development Authority, or BARDA, with respect to the Stop-Work Order the company recently received from BARDA and its pending decision regarding a recent In Process Review of its contract to support the development of laninamivir octanoate.  Biota Pharmaceuticals Inc(NASDAQ:BOTA) has … Continue reading Pharma Stocks on Watch: Biota Pharmaceuticals Inc(NASDAQ:BOTA), Merck & Co., Inc.(NYSE:MRK), Intercept Pharmaceuticals Inc(NASDAQ:ICPT), Pfizer Inc.(NYSE:PFE)